Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin Dosage Strategy in Elderly Severe Pneumonia
NCT04088305Phase 4Completed
- Sponsor
- Peking University Third Hospital
- Start
- Oct 2019
- Primary completion
- May 2022
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in Staphylococcal pneumonia, sponsored by Peking University Third Hospital. Started Oct 2019; status: completed.
02
Drugs
vancomycin
03
Conditions
Staphylococcal pneumonia
Beyond the preview
Go deeper on NCT04088305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04088305.